Results 81 to 90 of about 5,314 (201)
The Kaohsiung Journal of Medical Sciences, Volume 41, Issue 11, November 2025.ABSTRACT This study examines the impact of hepatitis C virus (HCV) eradication through sofosbuvir/velpatasvir (SOF/VEL) treatment on glycated hemoglobin (HbA1c) levels in patients with chronic hepatitis C and type 2 diabetes mellitus (T2DM). Utilizing data from the Taiwan HCV Registry, a retrospective analysis was conducted on 2180 patients who met the
Szu‐Jen Wang +43 more
wiley +1 more source
Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. [PDF]
, 2016 Background & Aims: Life expectancy of patients with compensated hepatitis C virus (HCV) cirrhosis achieving sustained virologic response (SVR) is limited by liver events as compared to the general population. Thus, survival benefit of SVR remains to
Aghemo A +12 more
core +1 more source
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam
Journal of Viral Hepatitis, Volume 32, Issue 11, November 2025.ABSTRACT People who inject drugs (PWID) are highly affected by hepatitis C (HCV) worldwide, particularly in low‐ and middle‐income countries (LMICs), where access to addiction services is often limited. Reducing the burden of HCV, as promoted by WHO, requires effective interventions in this high‐risk population.
Didier Laureillard +21 more
wiley +1 more source
Journal of Viral Hepatitis, Volume 32, Issue 11, November 2025.ABSTRACT Improved HCV diagnosis and linkage to care is crucial to achieve WHO 2030 elimination targets. Simplification of diagnostics remains key. We evaluated the performance of Elecsys HCV Duo antigen/antibody immunoassay in patients using public healthcare in Cape Town, South Africa. 253 HCV seropositive and 214 seronegative samples were tested, and
Diana R. Hardie +6 more
wiley +1 more source
Developing a community HCV service: project ITTREAT (Integrated Community based Test - stage - TREAT) service for people who inject drugs [PDF]
, 2017 Liver disease is now the third most common cause of premature death in the UK, with chronic viral hepatitis being an important contributory factor.
Hashim, Ahmed +3 more
core +1 more source
Multicomponent Synthesis of Fluorine‐Containing Bioactive Compounds and Drugs
European Journal of Organic Chemistry, Volume 28, Issue 38, October 15, 2025.Multicomponent reactions are robust synthetic tools to assamble complex polyheterocycles and other interesting molecular architectures with potential application in medicinal chemistry, including their fluorine‐containing analogues. Fluorine atoms placed strategically into bioactive molecules often enhance essential pharmacokinetic parameters like ...
Ivette Morales‐Salazar +7 more
wiley +1 more source
Revista da Sociedade Brasileira de Medicina Tropical, 2020 INTRODUCTION We conducted a cost-utility analysis of available interferon-free treatments for patients with early-stage genotype 1 chronic hepatitis C based on a Brazilian public health system perspective.
Vinicius Lins Ferreira +3 more
doaj +1 more source
Hepatocellular carcinoma [PDF]
, 2018 Liver cancer is the second leading cause of cancer-related deaths globally and has an incidence of approximately 850,000 new cases per year. Hepatocellular carcinoma (HCC) represents approximately 90% of all cases of primary liver cancer.
Gores, Gregory +6 more
core +1 more source
Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection [PDF]
The Korean Journal of Internal Medicine, 2023 Hyun Phil Shin
doaj +1 more source
Противовирусные лекарственные средства для лечения гепатита C [PDF]
, 2019 ГЕПАТИТ C /ЛЕК ТЕРПАРЕНТЕРАЛЬНО-ПЕРЕДАВАЕМЫЙ ГЕПАТИТ НИ-A, НИ-B /ЛЕК ТЕРПРОТИВОВИРУСНЫЕ СРЕДСТВА /ХИМЛЕКАРСТВ ХИМИЧЕСКАЯ СТАБИЛЬНОСТЬИНГИБИТОРЫ ПРОТЕАЗЫ NS3/NS4АИНГИБИТОРЫ БЕЛКА NS5AИНГИБИТОРЫ NS5B ПОЛИМЕРАЗЫДан обзор химической структуры и её связи с ...
Жерносек, А. К. +1 more
core